Clinical Trial Update: Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating olopatadine hydrochloride ophthalmic solution versus vehicle in Japanese subjects with acute allergic conjunctivitis using the CAC mode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• olopatadine HCl ophthalmic solution (olopatadine hydrochloride)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED